| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $70.1M | +93.7% |
| SG&A Expense | $32.7M | +99.6% |
| Operating Income | -$102.8M | -95.5% |
| Pre-tax Income | -$89.4M | -74.2% |
| Income Tax | $236K | +1288.2% |
| Net Income | -$89.6M | -74.6% |
| EPS (Basic) | -$0.81 | +85.3% |
| EPS (Diluted) | -$0.81 | +85.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $129.8M | +397.5% |
| Short-term Investments | $337.5M | +421.3% |
| Current Assets | $473.6M | +408.8% |
| Total Assets | $482.0M | +392.6% |
| Current Liabilities | $24.7M | +90.2% |
| Total Liabilities | $29.1M | +123.3% |
| Stockholders' Equity | $453.0M | +493.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$79.5M | -72.4% |
| Capital Expenditures | $2.2M | +1298.1% |
| Investing Cash Flow | -$268.3M | -332.1% |
| Financing Cash Flow | $451.5M | +1456.3% |
| Free Cash Flow | -$81.7M | -76.5% |